New drug aims to help people lose fat, not muscle
NCT ID NCT06445075
Summary
This study tested whether adding a new drug called apitegromab to a standard weight loss medication could help overweight and obese adults. The main goal was to see if the combination helped people lose more body fat while preserving their lean muscle mass. Researchers measured changes in body composition over 24 weeks in about 100 adults without diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AdventHealth Translational Research Institute
Orlando, Florida, 32804, United States
-
Alliance for Multispecialty Research, LLC
Norman, Oklahoma, 73069, United States
-
Apex Mobile Clinical Research
Bellaire, Texas, 77401, United States
-
Clinical Trials of Texas, LLC dba Flourish Research
San Antonio, Texas, 78229, United States
-
Great Lakes Clinical Trials, LLC d/b/a Flourish Research
Chicago, Illinois, 60640, United States
-
ProSciento CRU
Chula Vista, California, 91911, United States
-
Tandem Clinical Research GI, LLC
Marrero, Louisiana, 70072, United States
Conditions
Explore the condition pages connected to this study.